FDA Adverse Event Injury Summary report: N

ON-Q PAIN PUMP

MDR report key: 2555824 · Received April 27, 2012

Report

Report Number
2026095-2012-00068
Event Type
Injury
Date Received
April 27, 2012
Date of Event
July 18, 2011
Report Date
April 4, 2012
Manufacturer
I-FLOW CORP.
Product Code
MEB
PMA / PMN Number
K063530
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

METHOD: NO PRODUCT WAS RETURNED FOR EVALUATION AND INVESTIGATION. THE LOT NUMBER WAS NOT PROVIDED; THEREFORE, THE DEVICE HISTORY RECORDS COULD NOT BE REVIEWED. RESULTS: THE INFORMATION CONTAINED IS FROM LEGAL DOCUMENTS SERVED ON I-FLOW CORPORATION. THE COMPLAINT WAS OPENED SO THAT A MEDICAL DEVICE REPORT (MDR) CAN BE FILED WITH THE US FOOD AND DRUG ADMINISTRATION. NO FURTHER INVESTIGATION WILL BE CONDUCTED. CONCLUSION: AS THIS COMPLAINT WAS CREATED FROM A LAWSUIT SERVED ON I-FLOW, NO CUSTOMER CONTACT CAN BE MADE AT THIS TIME DUE TO THE PENDING LITIGATION. AS OF (B)(4) 2006, I-FLOW HAS UPDATED ITS ON-Q PUMP DIRECTIONS FOR USE (DFU), TO INCLUDE THE FOLLOWING IN THE WARNINGS SECTION: "AVOID PLACING THE CATHETER IN JOINT SPACES. ALTHOUGH THERE IS NO DEFINITIVE ESTABLISHED CAUSAL RELATIONSHIP, SOME LITERATURE HAS SHOWN A POSSIBLE ASSOCIATION BETWEEN CONTINUOUS INTRA-ARTICULAR INFUSIONS (PARTICULARLY WITH BUPIVACAINE) AND THE SUBSEQUENT DEVELOPMENT OF CHONDROLYSIS." ((B)(4)). ON (B)(4) 2007, I-FLOW HAS ALSO PREPARED A TECHNICAL BULLETIN ENTITLED "WHAT WE KNOW ABOUT CHONDROLYSIS TODAY". ((B)(4)).

Description of Event or Problem · 1

DRUG/DILUENT: UNKNOWN. FILL VOLUME: UNKNOWN. FLOW RATE: UNKNOWN. PROCEDURE: RIGHT SHOULDER MANIPULATION. CATHPLACE: RIGHT SHOULDER JOINT. REFERENCE: 2026095-2012-00066 ((B)(4)) AND 2026095-2012-00067 ((B)(4)). PT ALLEGES CHONDROLYSIS FOLLOWING PLACEMENT OF AN I-FLOW PAINBUSTER AFTER SURGERY ON (B)(6) 2011.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ON-Q PAIN PUMP ELASTOMERIC PUMP MEB I-FLOW CORP. UNK UNK

Patients

Seq Age Sex Outcome Treatment
1 36 YR Other